CORRECTION article

Front. Pharmacol., 16 December 2024

Sec. Inflammation Pharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1532774

Corrigendum: Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation

  • 1. Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

  • 2. Jinzhou First People’s Hospital, Dalian, China

In the published article, there was an error in the Funding statement. The funding details for “Jinan Science and Technology Development Plan - Clinical Medicine Technology Innovation Plan (No. 202225049)” were erroneously omitted. The correct Funding statement appears below.

Statements

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by National Science Foundation for Young Scholars of China (Grant Nos 81500584 and 81200530), Youth Science Foundation of Shandong First Medical University (Shandong Academy of Medical Sciences) (No. 202201-062), the Science and Technology Development Plan Program of Medicine and Health of Shandong Province (No. 202103050761) and Jinan Science and Technology Development Plan - Clinical Medicine Technology Innovation Plan (No. 202225049).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

peritoneal dialysis, peritoneal fibrosis, apolipoprotein A-I, D-4F, oxidative stress, inflammation peritoneal dialysis, inflammation

Citation

Lu J, Gao J, Sun J, Wang H, Sun H, Huang Q, Zhang Y and Zhong S (2024) Corrigendum: Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation. Front. Pharmacol. 15:1532774. doi: 10.3389/fphar.2024.1532774

Received

25 November 2024

Accepted

02 December 2024

Published

16 December 2024

Volume

15 - 2024

Edited and reviewed by

Weicheng Hu, Yangzhou University, China

Updates

Copyright

*Correspondence: Jing Sun, ; Haiping Wang,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics